Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral Venous Pressure-Guided Decongestive Therapy in Heart Failure 2
NCT06495892Phase 4Active, not recruiting
- Sponsor
- Başakşehir Çam & Sakura City Hospital
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in heart failure (HF) (2 arms), sponsored by Başakşehir Çam & Sakura City Hospital. Primary endpoint: Major adverse events (Mortality and rehospitalization) at 1 year. Started Jul 2024; status: active, not recruiting.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06495892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06495892.